跳至主要内容
临床试验/NCT03754192
NCT03754192Unknown不适用

Prediction Value of Perfusion and Dual Energy Computer Tomography for Microvascular Invasion in Hepatocellular Carcinoma

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年1月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Pefusion parameters

研究概览

简要总结

The aim of this study is to evaluate the hepatic perfusion computer tomography and dual energy computer tomography in the assessment of tumor characterization of Hepatocellular carcinoma in patients with resectable Hepatocellular carcinoma by comparing the quantitative parameters computer tomography obtained with the pathological data of the surgical specimens.

详细描述

Dual-energy computer tomography and perfusion computer tomography (General Electric revolution Hight definition Gemstone™ Spectral Imaging) will be performed in all patients. Iodine concentration and quantitative perfusion parameters of the Hepatocellular carcinoma and surrounding liver parenchyma data will be compared with the pathological results.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •A diagnosis of Hepatocellular carcinoma made according to the guidelines of the American Association for the study of the Liver
  • •Affiliation to a national health insurance
  • •An indication for hepatic resection during the decision-making stage
  • •A request for a pre-operative Computer Tomography in our radiology unit
  • •An affiliation to a social security
  • •Informed consent given by the patient

排除标准

  • •Previous treatments of Hepatocellular carcinoma (medicated or surgical)
  • •Patient under tutorship or curatorship
  • •Pregnant or lactating woman

研究组 & 干预措施

perfusion computed tomography

Other

Will be realsed before liver surgery

干预措施: perfusion Computed Tomography (Radiation)

结局指标

主要结局

Pefusion parameters

时间窗: 5 minutes

correlation between pre-operative imaging data and histological data of Hepatocellular carcinoma

次要结局

  • Pathological examination(1 month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验